When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRNB - Principia Bio's cancer candidate PRN1371 shows encouraging action in early-stage study
Principia Biopharma Inc.
Results from a Phase 1 clinical trial evaluating Principia Biopharma's (PRNB+0.4%) PRN1371 in 36 patients with advanced solid tumors showed a favorable safety profile and encouraging efficacy. The data were presented at the AACR Bladder Cancer: Transforming the Field meeting in Denver, CO.
More news on: Principia Biopharma Inc., Healthcare stocks news,